TB-500 (Thymosin Beta-4): Claims, Evidence, and Safety Analysis
- TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cell migration and wound healing.
- Zero human clinical trials exist for any indication. All evidence comes from animal studies and in vitro experiments.
- Banned by the World Anti-Doping Agency (WADA) and multiple sporting bodies including the International Federation of Horseracing Authorities.
- Promoted in biohacking and bodybuilding communities for muscle recovery, injury healing, and hair growth , with no human safety data.
- Commonly sold as a “research chemical” alongside BPC-157, often from the same unregulated suppliers.
What Is TB-500?
TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4, a 43-amino-acid protein found in nearly all human cells. Thymosin Beta-4 plays a role in actin regulation (a protein essential for cell structure and movement), cell migration, and wound healing. It is naturally present in wound fluid and platelet-rich plasma.
The synthetic fragment TB-500 is marketed as a more stable, bioavailable version of the active region of Thymosin Beta-4. In laboratory settings, TB-500 has been studied for its effects on cell migration, angiogenesis (blood vessel formation), and inflammation regulation.
Like BPC-157, TB-500 has been enthusiastically adopted by biohacking and bodybuilding communities based on animal studies and anecdotal reports, despite the complete absence of human clinical trial data.
The Evidence: Animal Studies Only
All evidence for TB-500’s effects comes from rodent studies and in vitro cell experiments. No randomized controlled trial in humans has ever been conducted.
Reported effects in animals
- Accelerated wound closure in diabetic mice
- Promoted hair growth in rat models
- Reduced inflammation in rodent cardiac injury models
- Improved recovery in rat models of traumatic brain injury
These findings are scientifically interesting but cannot be extrapolated to humans. The biological systems involved (wound healing, angiogenesis, cell migration) are complex and species-specific. Compounds that show promise in controlled laboratory conditions frequently fail to demonstrate efficacy or safety in human trials.
What’s missing
- No human pharmacokinetic data , absorption, distribution, metabolism, and excretion are unknown
- No human safety data , adverse effects, contraindications, and long term consequences are unknown
- No dosing standards , dosages used in biohacking communities are based on animal studies scaled by body weight, a method that frequently produces dangerous errors
Doping Status and Regulatory Position
TB-500 is explicitly banned by the World Anti-Doping Agency (WADA) under category S2: Peptide Hormones, Growth Factors, and Related Substances. Athletes subject to testing face sanctions including multi-year suspensions for its use.
The International Federation of Horseracing Authorities has also banned TB-500 following its detection in multiple doping cases in thoroughbred racing.
In the United States, TB-500 is not approved by the FDA for any human use. It is sold under the “research use only” designation , a legal loophole that allows unregulated distribution of chemicals not intended for human consumption. The FDA does not verify the purity, potency, or safety of products sold under this designation.
How It’s Sold and Promoted
TB-500 is typically sold alongside BPC-157 as part of a “healing stack” by online peptide vendors. These products are manufactured primarily by Chinese chemical companies and sold direct-to-consumer through websites that prominently display disclaimers like “for research purposes only” and “not for human consumption” , while their marketing materials, forum discussions, and influencer promotions clearly target human use.
The peptide is typically sold as a lyophilized (freeze-dried) powder in vials, which users reconstitute with bacteriostatic water and self-inject subcutaneously or intramuscularly. Training on injection technique comes from YouTube videos and forum posts, not medical supervision.
Pricing ranges from approximately $30-80 per vial from direct suppliers, though domestic resellers mark up significantly. Unlike legitimate pharmaceuticals, there is no batch testing, no quality control, and no recourse if the product is contaminated, mislabeled, or incorrectly dosed.
Documented Safety Concerns
Without human trials, the full safety profile is unknown. However, specific concerns include:
1. Angiogenesis promotion: TB-500 stimulates blood vessel formation. While this may aid wound healing, unchecked angiogenesis is a mechanism by which tumors grow and metastasize. Systemically promoting angiogenesis without understanding the long term cancer risk is medically irresponsible.
2. Immunogenicity: As a synthetic peptide, TB-500 can trigger antibody production. The immune system may recognize it as foreign, potentially causing allergic reactions, injection-site inflammation, or autoimmune responses.
3. Contamination and misidentification: Independent testing of peptides sold online has found products containing incorrect peptides, harmful synthesis byproducts, bacterial contamination, and wildly variable potency. A vial labeled “TB-500 5mg” may contain 2mg of the wrong peptide with unknown impurities.
4. Unknown drug interactions: No data exists on how TB-500 interacts with prescription medications, other supplements, anesthesia, or pre-existing medical conditions.
5. Injection risks: Self-administered intramuscular or subcutaneous injections carry risks of infection, abscess formation, nerve damage, and injection of particulate matter from improperly reconstituted solutions.
evidence based Alternatives
For the conditions TB-500 is marketed to address, evidence based approaches exist that do not involve injecting unregulated research chemicals:
| Claimed TB-500 Benefit | evidence based Alternative |
|---|---|
| Muscle recovery | Adequate protein intake (1.6–2.2 g/kg/day), sleep optimization, periodized training |
| Wound healing | Proper wound care, adequate nutrition (protein, vitamin C, zinc), medical supervision |
| Hair growth | FDA-approved treatments (minoxidil, finasteride), nutritional assessment for deficiencies |
| Anti-inflammatory | Omega-3 fatty acids, curcumin, consistent exercise, adequate sleep |
Conclusion
TB-500 represents a case study in how laboratory findings are prematurely translated into consumer products without the intervening step of clinical research. The animal data is scientifically interesting but does not constitute evidence of safety or efficacy in humans.
Injecting an unregulated chemical manufactured overseas, purchased online, and reconstituted at home carries risks that cannot be quantified because the necessary studies have never been done. For athletes, the additional risk of a doping sanction makes TB-500 use particularly reckless.
Anyone considering peptide use for recovery or performance should ask: if this compound genuinely worked as claimed, why has no pharmaceutical company , with billions in R&D budgets and enormous financial incentive to develop wound-healing drugs , brought it through clinical trials?
References
[1] World Anti-Doping Agency. Prohibited List 2025. Category S2: Peptide Hormones and Growth Factors.
[4] US Food and Drug Administration. Interim Policy on Compounding Using Bulk Drug Substances. 2023.